 Home > Biochemistry News > Biotechnology News > Oncocross Announces Initiation of Global Phase 1 Clinical Trial of Investigational Therapy OC514

Oncocross Announces Initiation of Global Phase 1 Clinical Trial of Investigational Therapy OC514

 Last Update: 2022-04-30
 Source: Internet
 Author: User

Tags

forteo drug

zyrtec drug

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

A few days ago, Oncocross, an artificial intelligence-based drug development company, announced the initiation of a global Phase 1 clinical trial of its investigational therapy OC514 for the treatment of muscle diseases including sarcopenia

Sarcopenia is a disorder characterized by the deterioration of normal bodily functions due to the progressive loss of skeletal muscle mass and strength

Oncocross' drug discovery platform, called RAPTOR AI, uses an AI platform based on transcriptome data to discover innovative treatments, new indications for existing drugs, and indications for new drug combinations

Image source: Oncocross official website

Upon completion of the Phase 1 clinical trial, Oncocross plans to conduct a Phase 2 clinical trial of OC514 in cancer patients with sarcopenia

References:

[1] Oncocross Begins Clinical Trial for AI-Developed Drug for Sarcopenia.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.